Skip to main content
. 2019 Jun 24;27(9):1326–1340. doi: 10.1038/s41431-019-0435-0

Table 2.

Molecular defects and recurrence risks in AS

Genetic defect Proportion of cases [13] Recurrence risk
De novo deletion of 15q11q13 on the maternal chromosome 75% <1%a
Paternal uniparental disomy (UPD) of chromosome 15 1–2% <1%b
Imprinting defect (without an imprinting centre deletion) 3% <1%
Imprinting centre deletion ≈10–15% of patients with an imprinting defect 50% (if present in a non-mosaic state in the mother)
UBE3A mutation 5–10% 50% (if present in a non-mosaic state in the mother)
No identifiable molecular abnormality 10–15% Unknown (up to 50%)

aIf maternal karyotype is normal

bIf parental karyotypes are normal